Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 224,415,070 papers from all fields of science
Search
Sign In
Create Free Account
Arformoterol Tartrate
The tartrate salt of arformoterol, the (R,R)-enantiomer of formoterol and a long-acting beta-2 adrenergic agonist with bronchodilator activity…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Adrenergic beta2-Agonists [MoA]
arformoterol 0.0075 MG/ML Inhalant Solution [Brovana]
Narrower (1)
Brovana
Broader (1)
arformoterol
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Health resource utilization for inpatients with COPD treated with nebulized arformoterol or nebulized formoterol
V. Ganapathy
,
M. Stensland
International Journal of COPD
2017
Corpus ID: 13785125
Objective Arformoterol is the (R,R)-enantiomer of formoterol. Preclinical studies suggest that it is a stronger bronchodilator…
Expand
2016
2016
Exacerbations, health services utilization, and costs in commercially-insured COPD patients treated with nebulized long-acting β 2-agonists
Yaozhu J Chen
,
C. Makin
,
V. Bollu
,
M. Navaie
,
B. Celli
Journal of Medical Economics
2016
Corpus ID: 11260286
Abstract Objective: This retrospective cohort study compared exacerbations, health services utilization, and costs among chronic…
Expand
Review
2013
Review
2013
Nebulized arformoterol: what is its place in the management of COPD?
Matthew C. Miles
,
J. Donohue
,
J. Ohar
Therapeutic Advances in Respiratory Disease
2013
Corpus ID: 19515564
Chronic obstructive pulmonary disease (COPD) is a serious global health burden. Comprehensive management of COPD includes both…
Expand
Review
2012
Review
2012
Indacaterol (arcapta neohaler) for chronic obstructive pulmonary disease.
Rachel M. Slaton
,
Danielle L. Cruthirds
P & T : a peer-reviewed journal for formulary…
2012
Corpus ID: 30663138
Chronic obstructive pulmonary disease (COPD) is the collective term for a lower respiratory tract condition that includes chronic…
Expand
Review
2010
Review
2010
Arformoterol tartrate in the treatment of COPD
M. Cazzola
,
N. Hanania
,
M. Matera
Expert Review of Respiratory Medicine
2010
Corpus ID: 41727086
Some basic scientific data suggest that (S)-enantiomers of β2-agonists have different and sometimes opposing effects to (R…
Expand
2009
2009
Arformoterol tartrate in the treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease.
A. Madaan
Drugs of Today
2009
Corpus ID: 13527304
Arformoterol tartrate inhalational solution is a nebulized bronchodilator that has been approved for long-term, twice-daily…
Expand
Highly Cited
2007
Highly Cited
2007
Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.
R. Baumgartner
,
N. Hanania
,
W. Calhoun
,
S. Sahn
,
K. Sciarappa
,
J. Hanrahan
Clinical Therapeutics
2007
Corpus ID: 46220755
2007
2007
Compatibility of arformoterol tartrate inhalation solution with three nebulized drugs
P. Bonasia
,
C. Cook
,
Yufei Cheng
,
S. Ong
Current Medical Research and Opinion
2007
Corpus ID: 1997847
ABSTRACT Objective: Arformoterol tartrate inhalation solution (15 μg/2 mL) is approved for the twice-daily, long-term maintenance…
Expand
2006
2006
Arformoterol tartrate : β2-Adrenoceptor agonist prop innm; usan bronchodilator treatment of chronic obstructive pulmonary disease
P. Revill
,
N. Serradell
,
J. Bolós
,
M. Bayes
2006
Corpus ID: 78287464
β 2 -Adrenoceptor agonists are widely used as adjuncts to corticosteroids for the treatment of chronic obstructive pulmonary…
Expand
Review
2004
Review
2004
Arformoterol: (R,R)-eformoterol, (R,R)-formoterol, arformoterol tartrate, eformoterol-sepracor, formoterol-sepracor, R,R-eformoterol, R,R-formoterol.
Drugs in R&D
2004
Corpus ID: 6119930
Sepracor in the US is developing arformoterol [R,R-formoterol], a single isomer form of the beta(2)-adrenoceptor agonist…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE